Chiron Behring Vaccines Private Limited — Vaccine Exporter Profile
Indian Pharmaceutical Exporter · #9 for Vaccine · $5.5M export value · DGFT Verified
Chiron Behring Vaccines Private Limited is the #9 Indian exporter of Vaccine with $5.5M in export value and 111 verified shipments. Chiron Behring Vaccines Private Limited holds a 0.8% market share in Vaccine exports across 9 countries.
Chiron Behring Vaccines Private Limited — Vaccine Export Profile: Buyers & Destinations
Where Does Chiron Behring Vaccines Private Limited Export Vaccine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| THAILAND | $1.8M | 71 | 56.2% |
| PHILIPPINES | $656.3K | 14 | 20.4% |
| INDONESIA | $311.1K | 9 | 9.7% |
| MOZAMBIQUE | $199.7K | 6 | 6.2% |
| CAMBODIA | $100.0K | 3 | 3.1% |
| LESOTHO | $50.0K | 1 | 1.6% |
| SOUTH AFRICA | $50.0K | 1 | 1.6% |
| MYANMAR | $39.8K | 1 | 1.2% |
| BELGIUM | $323 | 5 | 0.0% |
Chiron Behring Vaccines Private Limited exports Vaccine to 9 countries. The largest destination is THAILAND accounting for 56.2% of Chiron Behring Vaccines Private Limited's Vaccine shipments, followed by PHILIPPINES (20.4%) and INDONESIA (9.7%). These destinations reflect Chiron Behring Vaccines Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Vaccine from Chiron Behring Vaccines Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| GLOVAX BIOTECH CORP. | PHILIPPINES | $556.3K | 12 |
| BIOGENETECH CO.LTD. | THAILAND | $500.0K | 23 |
| BIOGENETECH CO LTD | THAILAND | $450.0K | 15 |
| BIOGENETECH CO, LTD | THAILAND | $350.0K | 12 |
| BIOGENETECH CO LIMITED | THAILAND | $289.9K | 12 |
| AFRI FARMACIA LDA | MOZAMBIQUE | $199.7K | 6 |
| PT INAKA GLOBAL NET QQ. PT. TRIMAN | INDONESIA | $187.3K | 4 |
| BIOGENETECH CO.LIMITED | THAILAND | $172.0K | 7 |
| GLOVAX BIOTECH CORP | PHILIPPINES | $100.0K | 2 |
| PT.TRIMAN PHARMACEUTICAL INDUSTRIES | INDONESIA | $100.0K | 3 |
Chiron Behring Vaccines Private Limited supplies Vaccine to 17 buyers globally. The largest buyer is GLOVAX BIOTECH CORP. (PHILIPPINES), followed by BIOGENETECH CO.LTD. (THAILAND) and BIOGENETECH CO LTD (THAILAND). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Vaccine Export Value and How Much Does Chiron Behring Vaccines Private Limited Contribute?
India exported $313.3M worth of Vaccine through 14,355 shipments from 325 suppliers to 192 countries, serving 2,202 buyers globally. Chiron Behring Vaccines Private Limited contributes $5.5M to this total, accounting for 0.8% of India's Vaccine exports. Chiron Behring Vaccines Private Limited ships Vaccine to 9 countries through 17 buyers.
What Is the Average Shipment Value for Chiron Behring Vaccines Private Limited's Vaccine Exports?
Chiron Behring Vaccines Private Limited's average Vaccine shipment value is $50.0K per consignment, based on 111 shipments totaling $5.5M. The largest destination is THAILAND (56.2% of Chiron Behring Vaccines Private Limited's Vaccine exports).
How Does Chiron Behring Vaccines Private Limited Compare to Other Indian Vaccine Exporters?
Chiron Behring Vaccines Private Limited ranks #9 among 325 Indian Vaccine exporters with a 0.8% market share. The top 3 exporters are SERUM INSTITUTE OF INDIA PRIVATE LIMITED ($161.3M), BIOLOGICAL E. LIMITED ($43.0M), BHARAT BIOTECH INTERNATIONAL LIMITED ($30.4M). Chiron Behring Vaccines Private Limited processed 111 shipments to 9 destination countries.
What Vaccine Formulations Does Chiron Behring Vaccines Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICAL PRODUCTS:RABIES VACCINE 1X1 ML CHIRORAB | $885.7K | 20 |
| PHARMACEUTICAL PRODUCTS, RABIES VACCINE | $549.7K | 17 |
| PHARMACEUTICAL PRODUCTS: RABIES VACCINE1X1 ML CHIRORAB | $321.2K | 7 |
| PHARMACEUTICAL PRODUCTS:RABIES VACCINE 1 | $300.0K | 12 |
| PHARMACEUTICAL PRODUCTS RABIES VACCINE 1X1 ML CHIRORAB | $246.2K | 6 |
| PHARMACEUTICAL PRODUCTS RABIES VACCINE | $150.0K | 3 |
| PHARMACEUTICAL PRODUCTS: RABIES VACCINE1X1 ML CHIRORABVLS | $135.1K | 3 |
| PHARMACEUTICAL PRODUCTS RABIES VACCINE 1X 1 ML CHIRORAB | $100.0K | 2 |
| PHARMACEUTICAL PRODUCTS- RABIES VACCINE1X1 ML CHIRORAB (BATCH NO:R24072C) | $100.0K | 2 |
| PHARMACEUTICAL PRODUCTS: CHIRORAB VACCINE 1 ML | $100.0K | 2 |
Chiron Behring Vaccines Private Limited exports 39 distinct Vaccine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICAL PRODUCTS:RABIES VACCINE 1X1 ML CHIRORAB with 20 shipments worth $885.7K.
How Does Chiron Behring Vaccines Private Limited Compare to Nearest Vaccine Exporters?
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | BIOLOGICAL E LIMITED | $15.7M | 313 | 79 | $50.0K |
| 5 | PANACEA BIOTEC LIMITED | $11.7M | 234 | 58 | $50.0K |
| 9 | CHIRON BEHRING VACCINES PRIVATE LIMITED ★ | $5.5M | 111 | 9 | $50.0K |
| 10 | BRILLIANT BIO PHARMA PRIVATE LIMITED | $5.4M | 108 | 12 | $50.0K |
| 13 | HESTER BIOSCIENCES LIMITED | $5.3M | 681 | 25 | $7.8K |
Chiron Behring Vaccines Private Limited ranks #9 among 325 Indian Vaccine exporters. Average shipment value of $50.0K compared to the market average of $964.0K. The closest competitors by value are BIOLOGICAL E LIMITED and PANACEA BIOTEC LIMITED.
Which Indian Ports Ship Vaccine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 3,489 | 24.3% |
| SAHAR AIR | 2,995 | 20.9% |
| Bombay Air | 855 | 6.0% |
| HYDERABAD ACC (INHYD4) | 839 | 5.8% |
| HYDERABAD AIR | 805 | 5.6% |
| DELHI AIR CARGO ACC (INDEL4) | 752 | 5.2% |
| DELHI AIR | 581 | 4.0% |
| AHEMDABAD AIR ACC (INAMD4) | 373 | 2.6% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Vaccine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Vaccine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Chiron Behring Vaccines Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 111 individual customs records matching Chiron Behring Vaccines Private Limited exporting Vaccine, covering 39 formulations to 9 countries via 17 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 192+ countries, 2,202+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Vaccine Export Data from Chiron Behring Vaccines Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Chiron Behring Vaccines Private Limited's Vaccine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Chiron Behring Vaccines Private Limited
Company Profile
0 products · $0 total trade · 0 categories
Vaccine Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Chiron Behring Vaccines Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Vaccine. For current shipment-level data, contact TransData Nexus.